Home Industry Reports Custom Research Blogs About Us Contact us

Healthcare & Medical Devices

Industries We Cover

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Ocular Inflammation Treatment Market Size & Share, By Treatment Type (Corticosteroids, Antibiotics, Analgesics, Antivirals, Antifungals), Indication Cause (Trauma & Injury, Autoimmune Diseases), Route of Administration, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Ocular Inflammation Treatment Market was over USD 7.73 Billion in 2023 and is anticipated to surpass USD 11.74 Billion by end of the year 2032, observing around 4.6% CAGR between 2024 and 2032.

Published Date: Jun-2024

Patient Referral Tracking Systems Market Size & Share, By Type (Inbound, Outbound), Deployment Mode (Cloud-based, On-premise), End-user (Healthcare Providers, Healthcare Payers, Patients), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Patient Referral Tracking Systems Market crossed USD 9.37 Billion in 2023 and is estimated to reach USD 38.52 Billion by end of the year 2032, witnessing more than 17.7% CAGR between 2024 and 2032.

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Tacrolimus Market Size & Share, By Product Type (Injections, Tablets and Capsules, Ointments, Granules), Application (Dermatitis, Immunosuppression), End-use (Hospitals, Specialty Clinics), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Tacrolimus Market surpassed USD 6.8 Billion in 2023 and is anticipated to exceed USD 11.12 Billion by end of the year 2032, growing at over 5.8% CAGR between 2024 and 2032.

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Published Date: Jun-2024

Myeloproliferative Disorders Drugs/Treatment Market Size & Share, By Disorder Type (Ph+ CML, Ph- MPN [Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis]), Drug Class (Tyrosine Kinase, JAK), Route of Administration, End-use, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Myeloproliferative Disorders Drugs/Treatment Market was over USD 9.58 Billion in 2023 and is estimated to surpass USD 12.77 Billion by end of the year 2032, growing at over 3.3% CAGR between 2024 and 2032.

Published Date: Jun-2024